$348 Million is the total value of Atika Capital Management LLC's 158 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SERIES TRUSTput | $21,210,000 | – | 245,000 | +100.0% | 6.09% | – |
| ABBV | New | ABBVIE INCcall | $5,332,000 | – | 60,000 | +100.0% | 1.53% | – |
| HCA | New | HCA HEALTHCARE INCput | $4,775,000 | – | 60,000 | +100.0% | 1.37% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $4,536,000 | – | 100,000 | +100.0% | 1.30% | – |
| MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $4,295,000 | – | 87,000 | +100.0% | 1.23% | – |
| ALB | New | ALBEMARLE CORP | $3,953,000 | – | 29,000 | +100.0% | 1.14% | – |
| BIDU | New | BAIDU INCspon adr rep a | $3,715,000 | – | 15,000 | +100.0% | 1.07% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $3,190,000 | – | 61,500 | +100.0% | 0.92% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $3,187,000 | – | 50,000 | +100.0% | 0.92% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $3,134,000 | – | 58,000 | +100.0% | 0.90% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $3,111,000 | – | 122,000 | +100.0% | 0.89% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $2,937,000 | – | 25,000 | +100.0% | 0.84% | – |
| RHT | New | RED HAT INC | $2,772,000 | – | 25,000 | +100.0% | 0.80% | – |
| AKCA | New | AKCEA THERAPEUTICS INC | $2,491,000 | – | 90,000 | +100.0% | 0.72% | – |
| MYOK | New | MYOKARDIA INC | $2,399,000 | – | 56,000 | +100.0% | 0.69% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $2,051,000 | – | 23,000 | +100.0% | 0.59% | – |
| ROKU | New | ROKU INC | $1,911,000 | – | 72,000 | +100.0% | 0.55% | – |
| IMMU | New | IMMUNOMEDICS INC | $1,887,000 | – | 135,000 | +100.0% | 0.54% | – |
| RGNX | New | REGENXBIO INC | $988,000 | – | 30,000 | +100.0% | 0.28% | – |
| TPX | New | TEMPUR SEALY INTL INCcall | $968,000 | – | 15,000 | +100.0% | 0.28% | – |
| SAGE | New | SAGE THERAPEUTICS INCcall | $935,000 | – | 15,000 | +100.0% | 0.27% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $848,000 | – | 20,000 | +100.0% | 0.24% | – |
| MRNS | New | MARINUS PHARMACEUTICALS INC | $758,000 | – | 129,000 | +100.0% | 0.22% | – |
| MDCO | New | MEDICINES COcall | $740,000 | – | 20,000 | +100.0% | 0.21% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $686,000 | – | 13,700 | +100.0% | 0.20% | – |
| AXGT | New | AXOVANT SCIENCES LTDcall | $174,000 | – | 25,400 | +100.0% | 0.05% | – |
| REED | New | REEDS INC | $62,000 | – | 28,164 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MARTIN MARIETTA MATLS INC | 38 | Q3 2023 | 6.1% |
| NETFLIX INC | 35 | Q2 2023 | 5.6% |
| MICROSOFT CORP | 32 | Q3 2023 | 6.7% |
| AMAZON COM INC | 29 | Q3 2023 | 8.6% |
| LIBERTY MEDIA CORP DELAWARE | 29 | Q2 2023 | 5.3% |
| META PLATFORMS INC | 25 | Q3 2023 | 5.8% |
| INTUITIVE SURGICAL INC | 24 | Q3 2023 | 3.3% |
| ARGENX SE | 23 | Q3 2023 | 1.6% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 5.1% |
| EPAM SYS INC | 22 | Q3 2022 | 1.8% |
View Atika Capital Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Atika Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.